NephrosNEPH
13F holders, Q2 2024 (June 30)19holders +1
4new positions
3sold out
2famous investors
$2.12avg. 13F price*
At the end of Q2 2024, 19 institutions reported holding Nephros Inc. (NEPH) in their 13F filings, up 1 from Q1 2024. 4 opened new positions and 3 sold out. The largest holders were Wexford Capital LP ($7.6M), Vanguard Group Inc. ($409K) and Bard Associates Inc. ($371K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Nephros Inc.
- CUSIP
- 640671400
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $88K |
| Exits | 3 | $26K |
All 13F filers, Q1 2024 → Q2 2024: 86,906 shares bought and 19,017 shares sold, net +67,889 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| Wexford Capital LP | 1.94% | No change | 3,600,552 | $7.6M |
| Vanguard Group Inc. | 0.00% | Add +10.5% | 194,024 | $409K |
| Bard Associates Inc. | 0.14% | Reduce -2.1% | 175,596 | $371K |
| Geode Capital Management, LLC | 0.00% | Add +9.8% | 78,035 | $165K |
| HighTower Advisors, LLC | 0.00% | Reduce -1.7% | 57,210 | $121K |
| Renaissance Technologies | 0.00% | Reduce -0.5% | 41,000 | $87K |
| Blair William & Co. | 0.00% | No change | 36,249 | $76K |
| Elkhorn Partners Limited Partnership | 0.05% | No change | 36,000 | $76K |
| UBS Group AG | 0.00% | Add +6205.5% | 19,358 | $41K |
| Dimensional Fund Advisors LP | 0.00% | New | 17,631 | $37K |
| State Street Corp. | 0.00% | No change | 15,698 | $33K |
| Granite Investment Partners, LLC | 0.00% | Add +7.1% | 13,973 | $29K |
| Mesirow Financial Investment Management, Inc. | 0.00% | Reduce -10.3% | 13,800 | $29K |
| Independent Financial Group, LLC | 0.00% | New | 12,000 | $25K |
| Citadel Advisors | 0.00% | New | 11,848 | $25K |
| Morgan Stanley | 0.00% | No change | 5,423 | $11K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -16.5% | 3,673 | $8K |
| JPMorgan Chase & Co. | 0.00% | Add +0.5% | 222 | $469 |
| Bank of America Corp. | 0.00% | New | 76 | $160 |
"% of holder's portfolio" is NEPH's weight in each manager's 13F, not the share of Nephros Inc. the manager owns.